Tissue Eng Regen Med.  2022 Oct;19(5):891-912. 10.1007/s13770-022-00464-2.

Progress of Polysaccharide-Contained Polyurethanes for Biomedical Applications

• Ju DB
• Lee JC
• Hwang SK
• Cho CS
• Kim HJ

• KMID: 2533924
• DOI: http://doi.org/10.1007/s13770-022-00464-2

Abstract

Polyurethane (PU) has been widely examined and used for biomedical applications, such as catheters, blood oxygenators, stents, cardiac valves, drug delivery carriers, dialysis devices, wound dressings, adhesives, pacemaker, tissue engineering, and coatings for breast implants due to its mechanical flexibility, high tear strength, biocompatibility, and tailorable foams although bio-acceptability, biodegradability and controlled drug delivery to achieve the desired properties should be considered. Especially, during the last decade, the development of bio-based PUs has raised public awareness because of the concern with global plastic waste for creating more environmentally friended materials. Therefore, it is desirable to discuss polysaccharide (PS)-contained PU for the wound dressing and bone tissue engineering among biobased PUs because PS has several advantages, such as biocompatibility, reproducibility from the natural resources, degradability, ease of incorporation of bioactive agents, ease of availability and cost-effectiveness, and structural feature of chemical modification to meet the desired needs to overcome the disadvantages of PU itself by containing the PS into the PU.

Keyword

Polyurethane; Polysaccharide; Wound dressing; Bone tissue engineering